Silicon Valley wants you to live longer (or forever)

 

At $12.4 billion, San Diego biotech Samumed is one of the highest-valued healthcare startups in the country. It’s goal? Reverse aging.

Founded in 2008 by now-billionaire Osman Kibar, the company is focused on developing medicines that could (one day) do things like erase wrinkles or cure blindness. The key, Kibar thinks, lies in teaching our cells to regenerate—prompting progenitor stem cells back into action to help repair aging organs.

In August, Samumed raised $438 million in equity funding, a stunning investment for a company that, while promising, still has no approved drugs. To-date, it’s raised more than $650 million.

Credits: AngelList via Outlook

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.